Y! Health Sexual Health & STDs News

HPV infection rates similar in men and women (Reuters)

Reuters - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.
25% of Teen Girls Vaccinated for HPV (HealthDay)

HealthDay - THURSDAY, Oct. 9 (HealthDay News) -- About 25 percent of girls aged 11 to 17 have gotten the human papillomavirus vaccine known as Gardasil, which protects against cervical cancer, U.S. health officials reported Thursday.
Quarter of adolescent U.S. girls received HPV vaccine (Reuters)

Reuters - A quarter of girls aged 13-17 in the United States received Merck & Co's Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday.
Nobel Prize for Discovery of Cervical Cancer Virus (American Cancer Society)

American Cancer Society - A German scientist has won the Nobel Prize in Medicine, for his discoveries about the family of viruses that cause cervical cancer.
3 share Nobel prize for work on AIDS and cancer (AP)

AP - Three European scientists shared the 2008 Nobel Prize in medicine on Monday for separate discoveries of viruses that cause AIDS and cervical cancer, breakthroughs that helped doctors fight the deadly diseases.
More virulent strain of herpes hitting sumo wrestlers: study (AFP)

AFP - Japan's sumo wrestlers are vulnerable to a more virulent strain of a herpes skin virus, contracted through grappling their opponents, scientists said on Sunday.
New virus test may stop cervical cancer in rural women (Reuters)

Reuters - A new rapid test for the human papillomavirus (HPV), which can cause cervical cancer, has proven to be 90 percent accurate in a trial involving women in rural villages in eastern China.
Cervical cancer test poised to be a boon in developing world (AFP)

AFP - A simple test for cervical cancer, designed to be used in developing countries, could strike a massive blow against the disease notorious as a "silent killer" of women, doctors said on Sunday.
Gardasil Approved for Additional Uses (HealthDay)

HealthDay - MONDAY, Sept. 15 (HealthDay News) -- Gardasil, the vaccine used to guard against cervical cancer, has been approved for similar use against two more gynecological malignancies.

Y! Health Sexual Health & STDs News

Reuters - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.

HealthDay - THURSDAY, Oct. 9 (HealthDay News) -- About 25 percent of girls aged 11 to 17 have gotten the human papillomavirus vaccine known as Gardasil, which protects against cervical cancer, U.S. health officials reported Thursday.

Reuters - A quarter of girls aged 13-17 in the United States received Merck & Co's Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday.

American Cancer Society - A German scientist has won the Nobel Prize in Medicine, for his discoveries about the family of viruses that cause cervical cancer.

AP - Three European scientists shared the 2008 Nobel Prize in medicine on Monday for separate discoveries of viruses that cause AIDS and cervical cancer, breakthroughs that helped doctors fight the deadly diseases.

AFP - Japan's sumo wrestlers are vulnerable to a more virulent strain of a herpes skin virus, contracted through grappling their opponents, scientists said on Sunday.

Reuters - A new rapid test for the human papillomavirus (HPV), which can cause cervical cancer, has proven to be 90 percent accurate in a trial involving women in rural villages in eastern China.

AFP - A simple test for cervical cancer, designed to be used in developing countries, could strike a massive blow against the disease notorious as a "silent killer" of women, doctors said on Sunday.

HealthDay - MONDAY, Sept. 15 (HealthDay News) -- Gardasil, the vaccine used to guard against cervical cancer, has been approved for similar use against two more gynecological malignancies.